Another significant acquisition was in Compass Pathways PLC (NASDAQ:CMPS), with ARK purchasing 781,085 shares valued at $6,600,168 through its ARKG ETF. This purchase suggests a strategic interest in ...
When artificial intelligence (AI) chip maker NVIDIA Corporation (NVDA) heads for the exit, investors instinctively glance at the door. In its latest 13F filing, the chip giant disclosed that it had ...
Nvidia sold its entire stake in a drug-discovery company at the end of last year. ARK Invest is buying the stock.
For example, one of the things about modern English that would most strike a time traveler from the past is the frequency of “I was like …” among younger speakers, as in “And I was like ‘You don’t ...
Nvidia sold its entire 7.71M share stake as ARK Invest bought 1.25M shares; RXRX swung 14% before closing 2% higher Wednesday.
Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.
Major investors Nvidia and Novo Holdings A/S have fully exited their positions in Recursion Pharmaceuticals (NasdaqGS:RXRX), ...
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.53, indicating a +2.02% shift from the previous trading day.
In the biotech sphere, ARK continued its accumulation of CRISPR Therapeutics AG (NASDAQ:CRSP) by acquiring 37,075 shares worth $1.97 million. This purchase is part of a broader strategy, as ARK has ...
Recursion will host a (L)earnings Call on February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. The company will broadcast the live stream from Recursion’s X, LinkedIn, and YouTube accounts.
NVIDIA’s most recent 13F filing showed no position in Recursion Pharmaceuticals, indicating a complete exit from its previous holding of 7.71 million shares. The semiconductor giant had maintained its ...
Applied Digital shares dropped after Nvidia said it had sold its position in the AI infrastructure provider, as well as its stakes in Arm, Recursion Pharmaceuticals and WeRide. Nvidia disclosed in a ...